Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors.
- Author:
Michelle Kang KIM
1
Author Information
1. Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA. michelle.kim@mssm.edu
- Publication Type:Review
- Keywords:
Endoscopic ultrasound;
Neuroendocrine tumor;
Carcinoid;
Pancreas;
Stomach
- MeSH:
Carcinoid Tumor;
Gastrointestinal Neoplasms;
Gastrointestinal Tract;
Humans;
Neuroendocrine Tumors;
Pancreas;
Phenobarbital;
Stomach
- From:Gut and Liver
2012;6(4):405-410
- CountryRepublic of Korea
- Language:English
-
Abstract:
Endoscopic ultrasound (EUS) is an advanced endoscopic technique currently used in the staging and diagnosis of many gastrointestinal neoplasms. The proximity of the echoendoscope to the gastrointestinal tract lends itself to a detailed view of the luminal pathology and the pancreas. This unique ability enables endoscopists to use EUS in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Diagnostic EUS allows previously unidentified NETs to be localized. EUS also determines tumor management by staging the GEP-NETS, enabling the clinicians to choose the appropriate endoscopic or surgical management. The ability to obtain a tissue diagnosis with EUS guidance enables disease confirmation. Finally, recent developments suggest that EUS may be used to deliver therapeutic agents for the treatment of NETs. This review will highlight the advances in our knowledge of EUS in the clinical management of these tumors.
